Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Smoking Cessation Reduced RA Mortality Risk

Arthritis Care Res; ePub 2017 May 2; Sparks, et al

Sustained smoking cessation within 4 years of rheumatoid arthritis (RA) diagnosis reduced mortality risk, with a similar effect observed among non-RA comparators, a recent study found. Smoking >5 pack-years after RA diagnosis significantly increased mortality beyond the risk of non-RA comparators. Researchers identified an incident RA cohort in the Nurses' Health Study (NHS, 1976-2012). Behavioral data were collected through biennial questionnaires and they created a comparison cohort, matching RA cases to women without RA by age and calendar year at the index date of RA diagnosis. They found:

  • Among 121,701 women in the NHS, 938 were identified with incident RA matched to 8,951 non-RA comparators.
  • Among current smokers, 40.0% with RA permanently quit smoking in the early RA period compared to 36.1% of comparators.
  • There were 313 (33.4%) deaths in the RA cohort and 2,042 (22.8%) among comparators.
  • Compared to continued smoking, sustained cessation was associated with similarly decreased mortality in both the RA and comparison cohorts.
  • Women with RA had higher mortality for >5 post-RA pack-years than comparators with >5 post-index pack-years.

Citation:

Sparks JA, Chang S-C, Nguyen U-S DT, et al. Smoking behavior changes in the early rheumatoid arthritis period and risk of mortality during 36 years of prospective follow-up. [Published online ahead of print May 2, 2017]. Arthritis Care Res. doi:10.1002/acr.23269.